Abstract
Gastro-oesophageal reflux disease is common and is a chronic recurring condition. In view of our improved knowledge about the pathogenesis and complications of gastro-oesophageal reflux, the therapy should be individualized and a cost-effective approach should be attempted in its management.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adenocarcinoma / etiology
-
Algorithms
-
Antacids / economics
-
Antacids / therapeutic use
-
Anti-Ulcer Agents / therapeutic use
-
Esophageal Neoplasms / etiology
-
Esophagitis, Peptic / complications
-
Esophagitis, Peptic / diagnosis
-
Esophagitis, Peptic / therapy
-
Female
-
Gastroesophageal Reflux / complications
-
Gastroesophageal Reflux / diagnosis
-
Gastroesophageal Reflux / drug therapy*
-
Humans
-
Male
-
Middle Aged
-
Prevalence
Substances
-
Antacids
-
Anti-Ulcer Agents